Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

768561

registered interest
date	11/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Health Services: Foreign Nationals
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assessment they have made of the extent to which the changes brought in by National Health Service (Charges to Overseas Visitors) (Amendment) Regulations 2017 may exacerbate health inequalities; whether they have made any further estimate of the savings to be made since publishing their impact assessment; if so, what is the difference between those two estimates; and whether they plan to reconsider those changes.
tabling member printed	Lord Roberts of Llandudno
uin	HL1911
answer	answer is ministerial correction date of answer 18/10/2017 answer text <p>Following a detailed public consultation that ran from December 2015 to March 2016, the Government set out in its response to that consultation in February 2017 that it intended to amend the existing Charging Regulations. Over the course of the consultation and decision-making process, the Government carefully considered the impact the changes may have on public health, health inequalities and on vulnerable groups. The regulations providing for these changes were introduced on 19 July 2017 alongside a published impact assessment which estimated that the net income per annum as a result of the new regulations would be up to £40 million per year. While the Government monitors the implementation of the regulations and their effects, no further estimates on the net income have been made since the publication of the impact assessment.</p> answering member printed Lord O'Shaughnessy question first answered 18/10/2017 09:36:33 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	3691 label Biography information for Lord Roberts of Llandudno

768965

registered interest
date	11/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Royal Cornwall Hospitals NHS Trust
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to assist the Royal Cornwall Hospitals Trust since it has been placed into special measures.
tabling member constituency	North Cornwall
tabling member printed	Scott Mann
uin	107138
answer	answer is ministerial correction date of answer 18/10/2017 answer text <p>This is a matter for NHS Improvement. Special Measures for Quality is a targeted and time-limited regime agreed between the Care Quality Commission and NHS Improvement.</p><p> </p><p>We have been advised by NHS Improvement that a range of support has already been provided to Royal Cornwall Hospitals National Health Service Trust, including an Improvement Director to support the Trust in the development of an overarching improvement plan; buddying arrangements with the Royal Devon and Exeter NHS Foundation Trust and Plymouth Hospitals NHS Trust to provide peer executive support and improvement expertise; as well as a range of other clinical improvement activities. There is national dedicated funding available to any trust that is placed in Special Measures for Quality. Royal Cornwall Hospitals NHS Trust will have full access to this resource to support improvement activities.</p> answering member constituency Ludlow answering member printed Mr Philip Dunne question first answered 18/10/2017 14:23:52 answering member 1542 label Biography information for Philip Dunne
tabling member	4496 label Biography information for Scott Mann

768971

registered interest
date	11/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Crimes of Violence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what information (a) his Department, (b) NHS England and (c) arms-length bodies collect on the number of reported physical assaults on NHS staff.
tabling member constituency	Leigh
tabling member printed	Jo Platt
uin	107280
answer	answer is ministerial correction date of answer 18/10/2017 answer text <p>The NHS Staff Survey is used by the Department, NHS England and arm’s-length bodies to collect information on the percentage of staff experiencing physical violence from patients, relatives or the public in the last 12 months, the percentage of staff experiencing physical violence from staff in the last 12 months and the percentage of staff/colleagues reporting their most recent experience of violence.</p><p> </p><p>Working with their security staff, the Police and Crown Prosecution Service, employers are responsible for reducing the likelihood of staff being attacked and taking appropriate action against those assaulting their staff. Trusts can use the NHS Staff Survey to benchmark progress against their peers and help them review their plans for tackling violence against their staff.</p><p> </p><p>In 2016 (the latest NHS Staff Survey data available), 15% of staff reported they experienced physical violence from patients, relatives or members of the public in the last 12 months, a proportion which has remained static since 2012. In contrast, nearly all staff who participated in the survey reported that they have never experienced violence from a colleague (98%) or their manager (99%) in the last 12 months.</p><p> </p><p>From 2012 - 2016, the NHS Staff Survey has shown:</p><table><tbody><tr><td><p> </p></td><td><p>2012</p></td><td><p>2013</p></td><td><p>2014</p></td><td><p>2015</p></td><td><p>2016</p></td></tr><tr><td><p>Percentage of staff experiencing physical violence from patients, relatives or the public in the last 12 months</p></td><td><p>14.9%</p></td><td><p>14.9%</p></td><td><p>14.6%</p></td><td><p>14.8%</p></td><td><p>14.9%</p></td></tr><tr><td><p>Percentage of staff experiencing physical violence from staff in the last 12 months</p></td><td><p>2.7%</p></td><td><p>2.7%</p></td><td><p>2.7%</p></td><td><p>2.0%</p></td><td><p>2.0%</p></td></tr><tr><td><p>Of those experiencing physical violence, the percentage of them or their colleagues reporting the incident has remained broadly similar since 2012</p></td><td><p>73.8%</p></td><td><p>72.6%</p></td><td><p>72.3%</p></td><td><p>71.6%</p></td><td><p>72.0%</p></td></tr></tbody></table><p> </p> answering member constituency Ludlow answering member printed Mr Philip Dunne question first answered 18/10/2017 11:44:53 answering member 1542 label Biography information for Philip Dunne
tabling member	4673 label Biography information for Jo Platt

768973

registered interest
date	11/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Surgery: Waiting Lists
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what his policy is on the minimum waiting time for elective surgery; and if he will make a statement.
tabling member constituency	Ellesmere Port and Neston
tabling member printed	Justin Madders
uin	107228
answer	answer is ministerial correction date of answer 18/10/2017 answer text <p>The NHS Constitution outlines that patients have a right to start consultant-led treatment within a maximum of 18 weeks from referral for non-urgent conditions. If this is not possible, the National Health Service must take all reasonable steps to offer a suitable alternative provider that can treat them sooner, if this is clinically appropriate and it is what the patient wants.</p><p> </p><p>Clinical priority is the main determinant of when patients should be treated followed by the chronological order of when they were added to the list. Clinicians should make decisions about patients’ treatment and patients should not experience undue delay at any stage of their referral, diagnosis or treatment.</p><p> </p><p>It is for NHS commissioners and providers locally to work together to manage demand and plan sufficient capacity to maintain low waiting times.</p> answering member constituency Ludlow answering member printed Mr Philip Dunne grouped question UIN 107231 question first answered 18/10/2017 11:54:31 answering member 1542 label Biography information for Philip Dunne
tabling member	4418 label Biography information for Justin Madders

768975

registered interest
date	11/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Surgery: Waiting Lists
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what his Department's policy is on clinical commissioning groups introducing minimum waiting times for elective surgery.
tabling member constituency	Ellesmere Port and Neston
tabling member printed	Justin Madders
uin	107231
answer	answer is ministerial correction date of answer 18/10/2017 answer text <p>The NHS Constitution outlines that patients have a right to start consultant-led treatment within a maximum of 18 weeks from referral for non-urgent conditions. If this is not possible, the National Health Service must take all reasonable steps to offer a suitable alternative provider that can treat them sooner, if this is clinically appropriate and it is what the patient wants.</p><p> </p><p>Clinical priority is the main determinant of when patients should be treated followed by the chronological order of when they were added to the list. Clinicians should make decisions about patients’ treatment and patients should not experience undue delay at any stage of their referral, diagnosis or treatment.</p><p> </p><p>It is for NHS commissioners and providers locally to work together to manage demand and plan sufficient capacity to maintain low waiting times.</p> answering member constituency Ludlow answering member printed Mr Philip Dunne grouped question UIN 107228 question first answered 18/10/2017 11:54:31 answering member 1542 label Biography information for Philip Dunne
tabling member	4418 label Biography information for Justin Madders

768977

registered interest
date	11/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Doctors
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effect of the UK leaving the EU on the regulation, movement and education of doctors in the UK.
tabling member constituency	Ellesmere Port and Neston
tabling member printed	Justin Madders
uin	107233
answer	answer is ministerial correction date of answer 18/10/2017 answer text <p>The Department is working closely with the General Medical Council, Health Education England, NHS England and others in the health and care system to understand the impact of the United Kingdom leaving the European Union on doctors in the UK.</p> answering member constituency Ludlow answering member printed Mr Philip Dunne question first answered 18/10/2017 11:53:18 answering member 1542 label Biography information for Philip Dunne
tabling member	4418 label Biography information for Justin Madders

768103

registered interest
date	10/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the implications for his Department's policies of the findings of the Lancet article, entitled How will Brexit affect health and health services in the UK? Evaluating three possible scenarios, published in September 2017; and whether he has had discussions with the Secretary of State for Exiting the European Union on those implications.
tabling member constituency	Ellesmere Port and Neston
tabling member printed	Justin Madders
uin	106899
answer	answer is ministerial correction date of answer 18/10/2017 answer text <p>In the face of growing demand the National Health Service has record funding, so we have more doctors and more nurses on our wards. Ahead of this winter, the NHS has planned earlier and more thoroughly than ever before, supported by an extra £100 millon for accident and emergency departments and £2 billion funding for the social care system.</p><p>The Government is committed to a world-class NHS, which is why we are backing it with at least an extra £8 billion investment by 2022 and are focused on getting a Brexit deal that is in the best interests of the economy, citizens and patients.</p><p>The Department, through the Secretary of State, other Ministers and senior officials, are in regular contact with the Department for Exiting the European Union on all health and social care matters in relation to Brexit.</p> answering member constituency Ludlow answering member printed Mr Philip Dunne question first answered 18/10/2017 11:24:24 answering member 1542 label Biography information for Philip Dunne
tabling member	4418 label Biography information for Justin Madders

768104

registered interest
date	10/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment his Department has made of the potential effect on the supply of medical devices to NHS patients in the event that there is no transitional period prior to the UK leaving the EU during which to implement changes in EU law made before or during such a transitional period.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	106879
answer	answer is ministerial correction date of answer 18/10/2017 answer text <p>The Medicines and Healthcare products Regulatory Agency, the Office of Life Sciences, and the Department for Exiting the European Union are leading our work in this area.</p><p> </p><p>Medical devices are important for transforming health outcomes, and our top priority for the Life Sciences sector in the negotiations is to protect the safety of patients and ensure the integrity of cross-European public health systems.</p><p> </p><p>After the European Union referendum, the UK EU Life Sciences Steering Group was established to oversee a programme of work that is informing our departure from the EU. The group’s remit includes people and skills; research and grants; intellectual property; regulation and trade, manufacturing and supply - to organisations including the National Health Service.</p><p> </p><p>Regarding potential transposition of any changes in EU law, the general approach taken in the European Union (Withdrawal) Bill is that EU law which applies directly in the UK legal system immediately before exit will be converted into domestic law after exit. The purpose of the Bill is to provide a functioning statute book on the day we leave the EU, and it is designed to ensure that the United Kingdom exits the EU with certainty, continuity and control. After we leave the EU, Parliament will be free to change the law where it decides it is right to do so.</p><p> </p><p>In the negotiations the Government will discuss with the EU and Member States how best to continue to cooperate. We start from the position of having an aligned regulatory partnership and any changes should consider the impact on patient and public health. However, we appreciate that this is a negotiation, so we are prepared for all eventualities. Whatever the outcome we will protect the best interests of patients and the NHS.</p> answering member constituency Ludlow answering member printed Mr Philip Dunne question first answered 18/10/2017 14:30:42 answering member 1542 label Biography information for Philip Dunne
tabling member	151 label Biography information for Tom Brake

768106

registered interest
date	10/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Incinerators: Health Hazards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when the research on the effect of incineration on health commissioned by his Department and being undertaken by Imperial College, is expected to report.
tabling member constituency	Stroud
tabling member printed	Dr David Drew
uin	106907
answer	answer is ministerial correction date of answer 18/10/2017 answer text <p>Public Health England (PHE) funds the Small Area Health Statistics Unit (SAHSU) at Imperial College London and the Environmental Research Group at King’s College London. Both groups are part of the Medical Research Council-PHE Centre for Environment and Health and carry out studies to extend the evidence base regarding whether emissions from modern municipal waste incinerators affect human health.</p><p> </p><p>It is expected that papers from the project will be submitted by SAHSU to peer reviewed journals later this year, and that the papers are likely to be published a few months after submission.</p><p> </p><p>PHE’s existing position that well run and regulated modern municipal waste incinerators are not a significant risk to public health remains valid.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/10/2017 11:51:31 answering member 4067 label Biography information for Steve Brine
tabling member	252 label Biography information for Dr David Drew

768109

registered interest
date	10/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Eylea: Macular Degeneration
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions he has had with Lars Bruening, Bayer UK and Ireland CEO, as a result of the recognition by NICE of the merits of using Eylea to treat myopic choroidal neovascularisation.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	106900
answer	answer is ministerial correction date of answer 18/10/2017 answer text <p>No Ministerial discussions have taken place. The National Institute for Health and Care Excellence (NICE) is currently developing guidance on the use of Eylea for the treatment of myopic choroidal neovascularisation. NICE has published draft guidance that recommends use of the drug subject to a patient access scheme that makes the drug available to the National Health Service at a discounted price. NICE expects to publish final guidance this November. This is the first drug to be appraised through NICE’s new fast track appraisal process for treatments that can clearly demonstrate cost-effectiveness. Should the guidance remain unchanged, the NHS is committed to funding the treatment 30 days after NICE’s final guidance is published.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/10/2017 16:39:45 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon